ecancer

Advances in malignant melanoma

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany

11 Nov 2016

Editor's ESMO 2016 roundup

Prof Gordon McVie - Editor in Chief, ecancer

24 Oct 2016

ESMO 2016 conference highlights

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

12 Oct 2016

Comment: Ipilimumab in high risk stage III melanoma

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair

10 Oct 2016

How can we improve the reliability and quality of cancer registries?

Dr Ana-Maria Forsea - Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania

10 Oct 2016

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France

8 Oct 2016

Oncolytic virotherapy in the treatment of melanoma

Dr Robert Andtbacka - Huntsman Cancer Institute, Salt Lake City, USA

26 Sep 2016

What is the role of surgery in melanoma treatment?

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy

26 Sep 2016

The role of chemotherapy for metastatic melanoma

Prof Paul Lorigan - University of Manchester, Manchester, UK

26 Sep 2016

The timeline of adjuvant and neoadjuvant therapy for melanoma

Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France

23 Sep 2016

More from ecancer